恒玄科技公告，预计2025年半年度实现营业收入19.38亿元左右，同比增长26.58%左右。预计2025年半 年度实现归属于母公司所有者的净利润为3.05亿元左右，同比增长106.45%左右。归属于母公司所有者 的扣除非经常性损益的净利润为2.84亿元左右，同比增长153.37%左右。 ...

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board Chip Index decreased by 0.53% as of July 9, 2025, with mixed performance among constituent stocks [1] - The leading stocks included Weichuangxin up by 4.06%, Chip Source Micro up by 2.17%, and Naxin Micro up by 1.01%, while Anji Technology led the decline [1] - The Sci-Tech Chip ETF (588200) underwent a downward adjustment [1] Group 2 - The Sci-Tech Chip ETF had a turnover rate of 1.4% and a transaction volume of 396 million yuan during the trading session [3] - Over the past year, the average daily transaction volume of the Sci-Tech Chip ETF was 2.337 billion yuan, ranking first among comparable funds [3] - The latest scale of the Sci-Tech Chip ETF reached 28.432 billion yuan, marking a six-month high and also ranking first among comparable funds [3] - The ETF saw a net inflow of 100 million yuan recently, with a total of 455 million yuan net inflow over the last five trading days [3] - The latest financing buy-in amount for the ETF was 94.48 million yuan, with a financing balance of 1.49 billion yuan [3] - The net value of the Sci-Tech Chip ETF increased by 66.77% over the past year, ranking first among comparable funds [3] Group 3 - As of July 7, 2025, 49 listed companies had disclosed mid-year performance forecasts, with 37 companies expecting profit increases [4] - Semiconductor companies on the Sci-Tech Board, such as Tai Ling Micro and Chip Motion Technology, forecast significant profit growth for the first half of 2025 [4] - According to SEMI data, global semiconductor wafer manufacturers are accelerating capacity expansion to meet the rising demand from generative AI applications, with a projected 7% CAGR increase in 300mm capacity from 2024 to 2028 [4] - The Shanghai Stock Exchange has accepted IPO applications from domestic GPU companies, indicating a supportive environment for the AI semiconductor industry [4] Group 4 - The top ten weighted stocks in the Sci-Tech Chip Index as of June 30, 2025, included SMIC, Haiguang Information, and Cambrian, collectively accounting for 57.76% of the index [4] - The performance of individual stocks within the top ten showed slight declines, with SMIC down by 0.51% and Haiguang Information down by 0.31% [6] - Investors without stock accounts can access domestic chip investment opportunities through the Sci-Tech Chip ETF linked fund (017470) [6]

Group 1 - The Shanghai Medium Enterprises Composite Index (000020) opened high and rose by 1.18%, closing at 1325.48 points with a trading volume of 148.314 billion yuan [1] - Over the past month, the index has increased by 2.04%, by 16.23% over the last three months, and by 9.94% year-to-date [1] - The index is calculated using a free-float market capitalization weighting method, with a base date of December 28, 2007, set at 1000.0 points [1] Group 2 - The top ten weighted stocks in the index include: SMIC (5.22%), Cambrian (3.47%), Stone Technology (0.98%), Sitaiwei (0.9%), Huahai Qingke (0.85%), Pacific (0.82%), Hengxuan Technology (0.82%), Chufeng Power (0.77%), Tuojing Technology (0.7%), and Longxin Zhongke (0.66%) [1] - The index is composed entirely of stocks listed on the Shanghai Stock Exchange, with a 100% representation [1] Group 3 - The industry composition of the index includes: Information Technology (33.04%), Industrials (23.12%), Consumer Discretionary (11.13%), Health Care (10.53%), Materials (8.80%), Consumer Staples (4.97%), Communication Services (4.42%), Financials (1.75%), Real Estate (0.98%), Utilities (0.85%), and Energy (0.41%) [2] - The index samples are adjusted annually, with adjustments implemented on the next trading day after the second Friday of June [2] - Temporary adjustments to the index samples may occur under special circumstances, such as when a sample no longer meets the medium enterprise classification standards or when a sample is delisted [2]

Group 1 - The company held its 18th meeting of the second Supervisory Board on July 7, 2025, with all three supervisors present, confirming the legality and validity of the meeting procedures [1][3]. - The Supervisory Board approved the adjustment of the 2022 and 2023 restricted stock incentive plan, stating that the adjustments comply with relevant laws and regulations, and do not harm the interests of the company and its shareholders [1][3]. - The board also approved the cancellation of certain restricted stocks from the 2022 incentive plan, affirming that this action aligns with applicable laws and regulations [3][4]. Group 2 - The Supervisory Board confirmed that the conditions for the third vesting period of the 2022 restricted stock incentive plan have been met, allowing 150 incentive recipients to vest 428,852 shares [3][4].

Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng Law Firm confirms that the adjustments to the 2022 and 2023 restricted stock incentive plans of Hengxuan Technology (Shanghai) Co., Ltd. have met the necessary conditions for granting and the invalidation of certain unvested restricted stocks [1][12][18]. Group 1: Approval and Authorization - Hengxuan Technology has completed the necessary approvals and authorizations for the adjustments to the 2022 and 2023 restricted stock incentive plans, including independent opinions from the board of directors and verification from the supervisory board [5][6][12]. - The company held multiple meetings to review and approve various related proposals, including the adjustment of grant prices and the invalidation of certain restricted stocks [8][9][10][11]. Group 2: Specifics of the Adjustments - The adjustments to the grant prices for the restricted stocks are calculated based on the company's profit distribution and capital reserve conversion, resulting in a new grant price of approximately 69.67 yuan per share for the 2022 plan and 44.91 yuan per share for the 2023 plan [14][13]. - The number of restricted stocks granted has also been adjusted accordingly, with the total adjusted grants being approximately 1,804,426 shares for the 2022 plan and 2,922,770 shares for the 2023 plan [14][13]. Group 3: Vesting Conditions - The third vesting period for the 2022 restricted stock incentive plan is defined as from May 13, 2025, to May 12, 2026, with specific performance conditions that must be met for the stocks to vest [15][16]. - The performance targets include achieving a revenue of 3 billion yuan for the year 2024, which has been confirmed by an audit report [16]. Group 4: Invalidation of Unvested Stocks - A total of 112,460 shares of restricted stocks that were granted but not vested have been invalidated due to performance assessment results and the departure of certain employees [17]. - The invalidation process aligns with the regulations outlined in the company's incentive plan, ensuring compliance with the relevant management measures [17]. Group 5: Information Disclosure - The company is obligated to disclose information regarding the adjustments to the incentive plans and the invalidation of stocks in accordance with applicable laws and regulations [18][19].

Core Viewpoint - The company has adjusted its 2022 and 2023 restricted stock incentive plans, which includes changes to the grant price and the number of shares granted due to capital reserve transfers and cash dividends [1][10]. Summary by Sections 1. Approval Procedures for the Stock Incentive Plans - The company held meetings to review and approve the 2022 and 2023 restricted stock incentive plans, with independent directors providing opinions and the supervisory board verifying the related matters [2][4][5]. 2. Adjustments to Grant Price and Quantity - The adjusted grant price for the 2022 plan is approximately 69.67 CNY per share, down from 98.74 CNY, while the 2023 plan's adjusted grant price is approximately 44.91 CNY per share, down from 64.08 CNY [9]. - The number of shares granted under the 2022 plan is adjusted to approximately 1,804,426 shares, and for the 2023 plan, it is adjusted to approximately 2,922,770 shares, with reserved grants adjusted to approximately 337,914 shares [9]. 3. Impact of Adjustments - The adjustments to the incentive plans are not expected to have a substantial impact on the company's financial status or operational results, nor will they affect the stability of the core team or the continued implementation of the stock incentive plans [10]. 4. Supervisory Board Opinion - The supervisory board believes that the adjustments comply with relevant laws and regulations, and the necessary procedures have been followed, ensuring no harm to the company or shareholders' interests [10][11].

Core Viewpoint - The announcement details the fulfillment of conditions for the third vesting period of the restricted stock incentive plan, allowing 150 eligible participants to acquire a total of 428,852 shares at an adjusted price of 69.67 yuan per share [1][11]. Group 1: Stock Incentive Plan Overview - The total number of restricted stocks to be vested is 428,852 shares (adjusted) [1]. - The stock source is from the company's directed issuance of A-shares to incentive participants [1]. - The initial grant of restricted stocks under the 2022 incentive plan was 1,804,426 shares (adjusted), representing a certain percentage of the company's total equity [1]. Group 2: Vesting Schedule and Conditions - The vesting schedule includes four periods, with the third vesting period allowing for 30% of the shares to vest [2][3]. - The performance targets for each vesting period are set, with the third period requiring a revenue target of 3 billion yuan for 2024 [3][10]. - The vesting conditions include a minimum employment period of 12 months and meeting company-level performance targets [2][10]. Group 3: Approval and Compliance - The board of directors and the supervisory board have approved the fulfillment of vesting conditions for the third period, with a unanimous vote [10][13]. - The supervisory board confirmed that the 150 participants meet the eligibility criteria as per relevant laws and regulations [13]. - The company will handle the stock vesting and related registration procedures according to regulatory requirements [13][14].

证券代码：688608 证券简称：恒玄科技 公告编号：2025-032 恒玄科技（上海）股份有限公司 关于调整公司 2022 年、2023 年限制性股票激励计划 相关事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 恒玄科技（上海）股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日召 开了第二届董事会第十八次会议，第二届监事会第十八次会议，审议通过了《关 于调整公司 2022 年、2023 年限制性股票激励计划相关事项的议案》。现将有关 事项说明如下： 一、股权激励计划已履行的相关审批程序 同日，公司召开第一届监事会第十三次会议，审议通过了《关于<恒玄科技 （上海）股份有限公司 2022 年限制性股票激励计划（草案）>及其摘要的议案》 《关于<恒玄科技（上海）股份有限公司 2022 年限制性股票激励计划实施考核 管理办法>的议案》《关于核实公司<2022 年限制性股票激励计划首次授予激励 对象名单>的议案》，公司监事会对本激励计划的相关事项进行核实并出具了相关 核查意见。 2、2022 年 4 月 ...

证券代码：688608 证券简称：恒玄科技 公告编号：2025-033 恒玄科技（上海）股份有限公司 关于作废处理部分 2022 年限制性股票激励计划 已授予但尚未归属的限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 恒玄科技（上海）股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日召 开了第二届董事会第十八次会议及第二届监事会第十八次会议，审议通过了《关 于作废处理 2022 年限制性股票激励计划部分限制性股票的议案》。现将有关事项 说明如下： 一、2022 年限制性股票激励计划已履行的相关审批程序 1、2022 年 4 月 25 日，公司召开第一届董事会第十九次会议，审议通过了 《关于<恒玄科技（上海）股份有限公司 2022 年限制性股票激励计划（草案）> 及其摘要的议案》《关于<恒玄科技（上海）股份有限公司 2022 年限制性股票激 励计划实施考核管理办法>的议案》《关于提请公司股东大会授权董事会办理股权 激励相关事宜的议案》等相关议案。公司独立董事就激励计划相关议案发表了独 立意见。 ...

证券代码：688608 证券简称：恒玄科技 公告编号：2025-034 恒玄科技（上海）股份有限公司 2022 年限制性股票激励计划首次授予部分 第三个归属期符合归属条件的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、本次股权激励计划批准及实施情况 （一）本次股权激励计划方案及履行的程序 （1）股权激励方式：第二类限制性股票。 （2）授予数量：2022 年限制性股票激励计划（以下简称"激励计划"）首次 授予的限制性股票数量为 180.4426 万股（本次调整后），约占当前公司股本总额 16,793.7371 万股的 1.07%。 （3）授予价格：69.67 元/股（本次调整后），即满足授予条件和归属条件后， 激励对象可以每股69.67元的价格购买公司向激励对象增发的公司A 股普通股股 票。 （4）激励人数：授予人数 191 人，为公司技术骨干人员及业务骨干人员。 （5）激励计划首次授予的限制性股票的归属期限和归属安排具体如下： | 归属安排 | 归属时间 | | 归属权益数量占授 予权益总量的比 ...